Wednesday, October 29 |
||
International Network Meeting 5 Perioperative Immune Checkpoint Inhibitors |
Wednesday, October 29,
15:30-17:00 Room 3 CRYSTAL 3 (3F) |
|
---|---|---|
Chair | TBD (TBD) | |
15:30-16:00 |
Patient Selection and Biomarkers for Perioperative CIO therapy
Shao Weng Daniel Tan (National Cancer Centre Singapore, Singapore)
|
|
16:00-16:30 |
Refining the Timing: Neoadjuvant vs. Perioperative CIO Therapy
Terufumi Kato (Tokyo Metropolitan Komagome Hospital, Center for Clinical Research and Clinical Trials, Japan)
|
|
16:30-17:00 |
Surgical perspectives for Perioperative CIO Therapy
TBD (TBD)
|
|
Thursday, October 30 |
||
Symposium 09 Targeted Therapy |
Thursday, October 30,
15:30-17:00 Room 3 CRYSTAL 3 (3F) |
|
Chair | Sung Yong Lee (Korea University, Korea) | |
15:30-16:00 |
Targeting METex14 in NSCLC: Clinical Advances and Unmet Needs
Terufumi Kato (Tokyo Metropolitan Komagome Hospital, Center for Clinical Research and Clinical Trials, Japan)
|
|
16:00-16:30 |
New Frontiers in KRAS-mutant NSCLC: Therapeutic Strategies and Resistance
TBD (TBD)
|
|
16:30-17:00 |
Redefining First-Line Standards with Unprecedented Survival in ALK+NSCLC
Cheol-Kyu Park (Chonnam National University, Korea)
|
|
Friday, October 31 |
||
Meet the Expert 4 Lung Cancer - Consolidative Immune Checkpoint Inhibitors |
Friday, October 31,
07:30-08:15 Room 6 RUBY (3F) |
|
Chair | TBD (TBD) | |
07:30-08:15 |
Beyond chemoradiation therapy: Harnessing Immunotherapy to Conquer LA-NSCLC and SCLC-LS
James Yang (National Taiwan University Hospital, Taiwan)
|
|
Symposium 12 Lung Cancer Screening and Diagnosis |
Friday, October 31,
10:20-11:50 Room 3 CRYSTAL 3 (3F) |
|
Chair | TBD (TBD) | |
10:20-10:50 |
Lung Cancer Screening
Yeon Wook Kim (Seoul National University, Korea)
|
|
10:50-11:20 |
Liquid Biopsy
In Ae Kim (Konkuk University, Korea)
|
|
11:20-11:50 |
Tissue-Based Molecular Workup
TBD (TBD)
|